Kidney Organoid Development

About Rosebud Biosciences

Rosebud Biosciences is a San Francisco-based startup founded in 2021, operating at the intersection of synthetic biology, biologics, and AI/ML. The company's core technology involves creating '2.5D' organoids from patient-derived induced pluripotent stem cells (hiPSCs) to model disease progression and perform high-throughput drug screening. By focusing on longitudinal monitoring and scalable automation, Rosebud aims to accelerate the discovery of cures for the 95% of rare genetic diseases that have no targeted therapies, with an initial focus on cardiac, hepatic, and neural organoids.

Therapeutic Areas

Other Rare Genetic Diseases Drugs